Simulations Plus' (SLP) "Market Perform" Rating Reiterated at JMP Securities

Simulations Plus (NASDAQ:SLP - Get Free Report)'s stock had its "market perform" rating reissued by analysts at JMP Securities in a report issued on Wednesday,Benzinga reports.

Several other analysts have also issued reports on SLP. Wall Street Zen upgraded Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. KeyCorp upped their target price on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. Craig Hallum cut their price target on Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research note on Friday, June 13th. Finally, William Blair reissued an "outperform" rating on shares of Simulations Plus in a research note on Tuesday, June 3rd. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.25.

Simulations Plus Price Performance

Shares of SLP opened at $18.32 on Wednesday. The business's 50-day moving average is $30.39 and its 200-day moving average is $29.94. The company has a market capitalization of $368.42 million, a price-to-earnings ratio of 52.34 and a beta of 0.97. Simulations Plus has a fifty-two week low of $18.25 and a fifty-two week high of $49.71.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 9.18% and a return on equity of 7.86%. The firm had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. During the same period in the previous year, the firm posted $0.20 earnings per share. The firm's revenue was up 22.5% on a year-over-year basis. Equities research analysts expect that Simulations Plus will post 1.09 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the transaction, the director now owns 3,344,157 shares in the company, valued at $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 19.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Simulations Plus

Several large investors have recently modified their holdings of SLP. Jones Financial Companies Lllp lifted its position in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after acquiring an additional 427 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Simulations Plus in the fourth quarter worth about $39,000. Fifth Third Bancorp increased its stake in shares of Simulations Plus by 33.8% in the first quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock worth $36,000 after purchasing an additional 375 shares during the period. Tower Research Capital LLC TRC lifted its position in shares of Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares during the last quarter. Finally, AlphaQuest LLC boosted its stake in Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after purchasing an additional 2,243 shares during the period. 78.08% of the stock is owned by institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.